New injection shows promise for stubborn high cholesterol
NCT ID NCT06471218
Summary
This study tested whether a new injectable drug called SHR-1918 could safely lower cholesterol in people whose levels were not well controlled. Forty-four adults received either the drug or a placebo injection over 24 weeks to see how much it reduced their 'bad' LDL cholesterol. The goal was to see if this new approach could help manage a major risk factor for heart disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERLIPIDEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Meizhou People's Hospital
Meizhou, Guangdong, 514031, China
Conditions
Explore the condition pages connected to this study.